 Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19.The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India DCGI for the treatment of COVID-19, it said in a statement. 